本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

92.75
-3.1800-3.31%
成交量:4.03萬
成交額:382.46萬
市值:61.41億
市盈率:-45.82
高:95.81
開:95.71
低:92.75
收:95.93
52周最高:115.52
52周最低:14.67
股本:6,620.97萬
流通股本:5,688.40萬
量比:1.25
換手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
淨資產收益率:-18.23%
總資產收益率:-12.95%
市淨率:5.52
市盈率(LYR):-50.18

資料載入中...

2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/21

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/23

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

重要事件披露

Form 8-K - Current report
2024/09/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/14

重要事件披露

Form 8-K - Current report
2024/09/07

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/27

重要事件披露

Form 8-K - Current report
2024/08/27

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/16

重要事件披露

Form 8-K - Current report